Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001606302-26-000007

Chief Executive Officer acquired 756 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McMinn Rachel · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-22 Exercise or conversion : show line 1 in the form +756 $25.32 $19,142 1,345,063 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-22 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −756 0 D
Loading xslF345X06/wk-form4_1790966949.xml…